Envoy Medical, Inc. (NASDAQ:COCH) Short Interest Update

Envoy Medical, Inc. (NASDAQ:COCH) saw a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 355,300 shares, an increase of 657.6% from the October 31st total of 46,900 shares. Based on an average daily volume of 231,200 shares, the short-interest ratio is presently 1.5 days. Approximately 4.6% of the shares of the company are sold short.

Envoy Medical Trading Up 3.6 %

COCH opened at $2.29 on Thursday. The firm’s 50 day simple moving average is $2.62 and its two-hundred day simple moving average is $2.61. Envoy Medical has a 1-year low of $1.08 and a 1-year high of $11.46.

Wall Street Analyst Weigh In

COCH has been the subject of a number of research reports. Ascendiant Capital Markets boosted their target price on shares of Envoy Medical from $8.50 to $8.75 and gave the company a “buy” rating in a research note on Tuesday, September 3rd. Brookline Capital Management initiated coverage on Envoy Medical in a research report on Monday, October 14th. They set a “buy” rating and a $9.00 price objective for the company.

Institutional Investors Weigh In On Envoy Medical

An institutional investor recently bought a new position in Envoy Medical stock. Virtu Financial LLC purchased a new position in Envoy Medical, Inc. (NASDAQ:COCH) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 14,045 shares of the company’s stock, valued at approximately $55,000. Virtu Financial LLC owned approximately 0.07% of Envoy Medical as of its most recent SEC filing. Institutional investors own 8.59% of the company’s stock.

Envoy Medical Company Profile

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.